Table 2.

HR (95% CI) between statin use and non-cardiovascular mortality among early (1990–95) vs late (1996–98) study visits

Model	1990–95	1996–98
Prevalent users, unadjusted	0.60 (0.41, 0.87)	0.58 (0.46, 0.73)
Eligible prevalent users, unadjusted	0.70 (0.38, 1.30)	0.56 (0.37, 0.83)
Eligible prevalent users, adjusted	0.75 (0.39, 1.44)	0.79 (0.50, 1.26)
Eligible new users, unadjusted	0.44 (0.22, 0.88)	0.81 (0.52, 1.27)
Eligible new users, adjusted	0.49 (0.24, 1.00)	1.07 (0.64, 1.79)
Eligible new users, PS-matched	0.37 (0.15, 0.94)	1.25 (0.73, 2.14)